CEO gives insight into the reality of cancer research

April 7, 2015 10:31 AM

20 0

Brad Thompson, the head of a cancer research company known as Oncolytics Biotech, explains why it is so difficult to get such a treatment into today’s medical market.

Brad Thompson, the CEO of Oncolytics Biotech, while very excited to see CBS’60 Minutes bring attention to virus-based cancer treatments a couple weeks back, knows there is much more when it comes to treating a disease.

Read more

To category page